UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Guidelines for the welfare and use of animals in cancer research

British journal of cancer, 2010-05, Vol.102 (11), p.1555-1577

2010

Volltextzugriff (PDF)

Antibody specificity controls in vivo effector mechanisms of anti-CD20 reagents

Blood, 2004-04, Vol.103 (7), p.2738-2743

2004

Volltextzugriff (PDF)

Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas

Blood, 2004-09, Vol.104 (6), p.1793-1800

2004

Volltextzugriff (PDF)

Control of established melanoma by CD27 stimulation is associated with enhanced effector function and persistence, and reduced PD-1 expression of tumor infiltrating CD8(+) T cells

Journal of immunotherapy, 2010-10, Vol.33 (8), p.769-779

2010

Volltextzugriff (PDF)

Complement-mediated lysis by anti-CD20 mAb correlates with segregation into lipid rafts

Blood, 2003-02, Vol.101 (3), p.1045-1052

2003

Volltextzugriff (PDF)

Renaissance of cancer therapeutic antibodies

Drug Discovery Today, 2003-06, Vol.8 (11), p.503-510

2003

Volltextzugriff (PDF)

CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help

Nature medicine, 1999-05, Vol.5 (5), p.548-553

1999

Volltextzugriff (PDF)

CD20-induced lymphoma cell death is independent of both caspases and its redistribution into triton X-100 insoluble membrane rafts

Cancer research (Chicago, Ill.), 2003-09, Vol.63 (17), p.5480-5489

2003

Volltextzugriff (PDF)

Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4‐1BB), and their role in the generation of anti‐tumor immune responses

European journal of immunology, 2002-12, Vol.32 (12), p.3617-3627

2002

Volltextzugriff (PDF)

Rituximab: mechanisms and applications

British journal of cancer, 2001-11, Vol.85 (11), p.1619-1623

2001

Volltextzugriff (PDF)

CD27 STIMULATION ENHANCES CD20 MAB THERAPY THROUGH ACTIVATION OF INNATE IMMUNITY

Hematological oncology, 2017-06, Vol.35 (S2), p.134-135

2017

Volltextzugriff (PDF)

Analysis of the oligomeric requirement for signaling by CD40 using soluble multimeric forms of its ligand, CD154

European journal of immunology, 2001-10, Vol.31 (10), p.3094-3100

2001

Volltextzugriff (PDF)

Anti-CD40 monoclonal antibody therapy in combination with irradiation results in a CD8 T-cell–dependent immunity to B-cell lymphoma

Blood, 2003-08, Vol.102 (4), p.1449-1457

2003

Volltextzugriff (PDF)

Signaling antibodies in cancer therapy

Current Opinion in Immunology, 1999-10, Vol.11 (5), p.541-547

1999

Volltextzugriff (PDF)

Chimeric IgA antibodies against HLA class II effectively trigger lymphoma cell killing

Blood, 2002-12, Vol.100 (13), p.4574-4580

2002

Volltextzugriff (PDF)

Triggering Fc alpha-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy

The Journal of immunology (1950), 2000-11, Vol.165 (10), p.5954-5961

2000

Volltextzugriff (PDF)

T Cell Immunity to Lymphoma Following Treatment with Anti-CD40 Monoclonal Antibody

The Journal of immunology (1950), 2002-03, Vol.168 (6), p.2720-2728

2002

Volltextzugriff (PDF)

Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide

Journal of immunological methods, 2001-06, Vol.252 (1), p.83-92

2001

Volltextzugriff (PDF)

Cytotoxic CD4+ T cells in patients with B cell chronic lymphocytic leukemia kill via a perforin-mediated pathway

Haematologica (Roma), 2004-04, Vol.89 (4), p.435

2004

Volltextzugriff (PDF)

A new anti-idiotype antibody capable of binding rituximab on the surface of lymphoma cells

Blood, 2004-10, Vol.104 (8), p.2540-2542

2004

Volltextzugriff (PDF)

Multivalent Conjugates of Poly-γ-d-glutamic Acid from Bacillus licheniformis with Antibody F(ab‘) and Glycopeptide Ligands

Bioconjugate chemistry, 2003-11, Vol.14 (6), p.1148-1155

2003

Volltextzugriff (PDF)

Therapeutic efficacy of FcγRI/CD64-directed bispecific antibodies in B-cell lymphoma

Blood, 2000-11, Vol.96 (10), p.3544-3552

2000

Volltextzugriff (PDF)

The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis

Blood, 2002-11, Vol.100 (9), p.3068-3076

2002

Volltextzugriff (PDF)

Monoclonal Antibody Therapy of B Cell Lymphoma: Signaling Activity on Tumor Cells Appears More Important Than Recruitment of Effectors

The Journal of immunology (1950), 1998-09, Vol.161 (6), p.3176-3185

1998

Volltextzugriff (PDF)

Mechanisms of G-CSF- or GM-CSF-stimulated tumor cell killing by Fc receptor-directed bispecific antibodies

Journal of immunological methods, 2001-02, Vol.248 (1), p.103-111

2001

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(72)

Publikationsform

Artikel
(93)

Sprache

Englisch
(93)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(73)
Science & Technology
(73)
Animals
(53)
Humans
(48)
Biological And Medical Sciences
(44)
Mice
(38)
Medical Sciences
(34)
Immunotherapy
(29)
Immunology
(28)
Antibodies, Monoclonal - Therapeutic Use
(22)
Antibodies, Monoclonal - Immunology
(20)
Tumor Cells, Cultured
(20)
Antineoplastic Agents
(18)
Hematology
(18)
Mice, Inbred Balb C
(18)
Pharmacology. Drug Treatments
(17)
Oncology
(16)
Immunoglobulin Fab Fragments - Immunology
(14)
Immunoglobulin Idiotypes - Immunology
(14)
B-Lymphocytes - Immunology
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Guidelines for the welfare and use of animals in cancer research

Antibody specificity controls in vivo effector mechanisms of anti-CD20 reagents

Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas

Control of established melanoma by CD27 stimulation is associated with enhanced effector function and persistence, and reduced PD-1 expression of tumor infiltrating CD8(+) T cells

Complement-mediated lysis by anti-CD20 mAb correlates with segregation into lipid rafts

Renaissance of cancer therapeutic antibodies

CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help

CD20-induced lymphoma cell death is independent of both caspases and its redistribution into triton X-100 insoluble membrane rafts

Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4‐1BB), and their role in the generation of anti‐tumor immune responses

Rituximab: mechanisms and applications

CD27 STIMULATION ENHANCES CD20 MAB THERAPY THROUGH ACTIVATION OF INNATE IMMUNITY

Analysis of the oligomeric requirement for signaling by CD40 using soluble multimeric forms of its ligand, CD154

Anti-CD40 monoclonal antibody therapy in combination with irradiation results in a CD8 T-cell–dependent immunity to B-cell lymphoma

Signaling antibodies in cancer therapy

Chimeric IgA antibodies against HLA class II effectively trigger lymphoma cell killing

Triggering Fc alpha-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy

T Cell Immunity to Lymphoma Following Treatment with Anti-CD40 Monoclonal Antibody

Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide

Cytotoxic CD4+ T cells in patients with B cell chronic lymphocytic leukemia kill via a perforin-mediated pathway

A new anti-idiotype antibody capable of binding rituximab on the surface of lymphoma cells

Multivalent Conjugates of Poly-γ-d-glutamic Acid from Bacillus licheniformis with Antibody F(ab‘) and Glycopeptide Ligands

Therapeutic efficacy of FcγRI/CD64-directed bispecific antibodies in B-cell lymphoma

The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis

Monoclonal Antibody Therapy of B Cell Lymphoma: Signaling Activity on Tumor Cells Appears More Important Than Recruitment of Effectors

Mechanisms of G-CSF- or GM-CSF-stimulated tumor cell killing by Fc receptor-directed bispecific antibodies

Suchergebnisse filtern